Cardiac Injury Model
Cardiac Injury Model - Related Videos
10:25
Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
0 Views •
Cited by 20 •
2011
A powerful model for perioperative and critical care related acute kidney injury is presented. Using whole body hypoperfusion induced by cardiac arrest it is possible to nearly replicate the histologic and functional changes of clinical AKI.
10:41
A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids
0 Views •
2026
Self-assembling human cardiac organoids (hCOs) are an emerging system for modeling human cardiac development and disease. Here, a methodology for generating and injuring hCOs with hypoxia-reoxygenation and details of expected histological and functional outcomes after injury are provided.
04:19
A Mouse Model of Single and Repetitive Mild Traumatic Brain Injury
0 Views •
Cited by 16 •
2017
Athletes absorb several hundred mild traumatic brain injuries (mTBI)/concussions every year; however, the consequence of these on the brain is poorly understood. Therefore, an animal model of single and repetitive mTBI that consistently replicates clinically relevant symptoms provides the means to advance the study of mTBI and concussion.
11:04
Lateral Fluid Percussion: Model of Traumatic Brain Injury in Mice
0 Views •
Cited by 125 •
2011
Lateral fluid percussion (LFP), an established model of traumatic brain injury in mice, is demonstrated. LFP fulfills three major criteria for animal models: validity, reliability and clinical relevance. The procedure, consisting of surgical craniotomy, fixation of hub followed by induction of injury, resulting in focal and diffuse injuries, is described.
07:48
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
0 Views •
Cited by 37 •
2016
This protocol describes a highly reproducible model of cardiac regeneration by surgical induction of myocardial infarction in the left ventricle of postnatal day 1 mice. The method involves induction of hypothermic anesthesia and ligation of the left anterior descending coronary artery.
FAQs
The injury stimulus determines the type of cardiac stress being reproduced. Ischemia-reperfusion, pressure overload, and toxic exposure represent distinct experimental conditions, so each can emphasize different consequences of myocardial damage. Selecting among them helps researchers investigate disease or stress responses in a controlled way and relate the resulting cellular changes to clinically relevant heart dysfunction.
Researchers commonly examine cardiomyocyte death, inflammation, fibrosis, and changes in electrical or contractile function. Together, these readouts connect cellular damage with structural remodeling and impaired heart performance. Measuring several responses rather than a single endpoint can show how injury progresses from affected cardiomyocytes to broader tissue changes and functional consequences.
Cultured cells and engineered tissues allow investigators to study injury-related mechanisms at cellular or tissue levels, whereas animal systems help connect those mechanisms with whole-organ outcomes. Using more than one scale can clarify how cardiomyocyte responses, inflammation, fibrosis, and functional changes relate to one another across an experimental system.
A study generally establishes a controlled injury condition, such as ischemia-reperfusion, pressure overload, or toxic exposure, and then evaluates the resulting biological and functional changes. Investigators may assess cell death, inflammation, fibrosis, electrical behavior, or contractile performance. This workflow links the imposed stress to measurable myocardial outcomes.
These models are used to investigate myocardial infarction, heart failure, and cardiac repair. They can also support evaluation of candidate drugs, biomarkers, and regenerative strategies. The appropriate system depends on whether the study emphasizes cellular injury, tissue responses, or whole-organ consequences, allowing research questions to be examined at a relevant biological level.
Cardiac injury models provide a controlled setting for examining disease-related damage and testing potential interventions before clinical testing. Outcomes such as fibrosis, inflammation, electrical changes, and contractile dysfunction can help characterize treatment effects or biomarker relevance. Their value lies in connecting experimental myocardial responses with therapeutic and regenerative research decisions.